AGI.do

Products

What will AGI do for Alectinib?

Alectinib is an oral drug that blocks the activity of anaplastic lymphoma kinase (ALK) and is used to treat non-small-cell lung cancer (NSCLC).

How AGI delivers it

Four ways AGI delivers for Alectinib

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alectinib, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alectinib, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alectinib connects

measured by

  • Active Ingredient Assaymodel
  • Capsule Dose Weightmodel
  • Content Uniformitymodel
  • Dissolution Ratemodel
  • Related Substances Puritymodel

Go deeper

Explore Alectinib

Read the deeper take on agi.asView as markdown